88 related articles for article (PubMed ID: 11459995)
1. Phase I trial of i.v. administered tirapazamine plus cyclophosphamide.
Hoff PM; Saad ED; Ravandi-Kashani F; Czerny E; Pazdur R
Anticancer Drugs; 2001 Jul; 12(6):499-503. PubMed ID: 11459995
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
Aquino VM; Weitman SD; Winick NJ; Blaney S; Furman WL; Kepner JL; Bonate P; Krailo M; Qu W; Bernstein M
J Clin Oncol; 2004 Apr; 22(8):1413-9. PubMed ID: 15084615
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.
Shulman LN; Buswell L; Riese N; Doherty N; Loeffler JS; von Roemeling RW; Coleman CN
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):349-53. PubMed ID: 10760430
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Plager C; McIntyre S; Viallet J
Anticancer Drugs; 1999 Sep; 10(8):735-9. PubMed ID: 10573206
[TBL] [Abstract][Full Text] [Related]
5. Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.
Lara PN; Frankel P; Mack PC; Gumerlock PH; Galvin I; Martel CL; Longmate J; Doroshow JH; Lenz HJ; Lau DH; Gandara DR
Clin Cancer Res; 2003 Oct; 9(12):4356-62. PubMed ID: 14555506
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.
Johnson CA; Kilpatrick D; von Roemeling R; Langer C; Graham MA; Greenslade D; Kennedy G; Keenan E; O'Dwyer PJ
J Clin Oncol; 1997 Feb; 15(2):773-80. PubMed ID: 9053504
[TBL] [Abstract][Full Text] [Related]
7. Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.
Doherty N; Hancock SL; Kaye S; Coleman CN; Shulman L; Marquez C; Mariscal C; Rampling R; Senan S; Roemeling RV
Int J Radiat Oncol Biol Phys; 1994 May; 29(2):379-82. PubMed ID: 8195037
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer.
Rischin D; Narayan K; Oza AM; Mileshkin L; Bernshaw D; Choi J; Hicks R; McClure B; Fyles A
Int J Gynecol Cancer; 2010 Jul; 20(5):827-33. PubMed ID: 20606530
[TBL] [Abstract][Full Text] [Related]
9. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
von Pawel J; von Roemeling R; Gatzemeier U; Boyer M; Elisson LO; Clark P; Talbot D; Rey A; Butler TW; Hirsh V; Olver I; Bergman B; Ayoub J; Richardson G; Dunlop D; Arcenas A; Vescio R; Viallet J; Treat J
J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
[TBL] [Abstract][Full Text] [Related]
10. Tirapazamine-cisplatin: the synergy.
Gatzemeier U; Rodriguez G; Treat J; Miller V; von Roemeling R; Viallet J; Rey A
Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):15-7. PubMed ID: 9647615
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR;
Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179
[TBL] [Abstract][Full Text] [Related]
12. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
13. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
Williamson SK; Crowley JJ; Lara PN; McCoy J; Lau DH; Tucker RW; Mills GM; Gandara DR;
J Clin Oncol; 2005 Dec; 23(36):9097-104. PubMed ID: 16361616
[TBL] [Abstract][Full Text] [Related]
14. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial.
Graham MA; Senan S; Robin H; Eckhardt N; Lendrem D; Hincks J; Greenslade D; Rampling R; Kaye SB; von Roemeling R; Workman P
Cancer Chemother Pharmacol; 1997; 40(1):1-10. PubMed ID: 9137522
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
Aghajanian C; Brown C; O'flaherty C; Fleischauer A; Curtin J; Roemeling R; Spriggs DR
Gynecol Oncol; 1997 Nov; 67(2):127-30. PubMed ID: 9367694
[TBL] [Abstract][Full Text] [Related]
17. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
[TBL] [Abstract][Full Text] [Related]
18. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer.
Craighead PS; Pearcey R; Stuart G
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):791-5. PubMed ID: 11020576
[TBL] [Abstract][Full Text] [Related]
19. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
Senan S; Rampling R; Graham MA; Wilson P; Robin H; Eckardt N; Lawson N; McDonald A; von Roemeling R; Workman P; Kaye SB
Clin Cancer Res; 1997 Jan; 3(1):31-8. PubMed ID: 9815534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]